NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hedera Dx

Hedera Dx

Private
EpalingesHealthcare & Life Scienceshttps://www.hederadx.com/

Last Round

Series A

May 27, 2025

Total Funding Raised

$30.9M

Company Overview

Hedera Dx is a biotechnology company that develops and provides liquid biopsy solutions and software for hospital laboratories to conduct in-house, blood-based cancer testing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Data as a Service

AI Layer

Application

Keywords

liquid biopsyprecision oncologycancer diagnosticsnext-generation sequencingNGSctDNA testingtumor profilingRWEreal-world evidencedecentralized diagnosticsclinicogenomic dataIVD softwarevariant callingcompanion diagnosticsbioinformatics pipelinedigital pathology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hedera Dx Comparables

Compare Hedera Dx with similar companies based on industry and business-model similarity.

Hedera Dx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OncoDNA
77%
Avitia
76%
Illumina, Inc.
75%

Hedera Dx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 27, 2025
SeedSep 21, 2022

Key People

Founding team and executive leadership

Christian Meisel

Co-Founder, Chief Medical Officer

Founding Team

Damien Lapray

Co-Founder, Chief Commercial Officer

Founding Team

Tommi Lehtonen

Co-Founder, CEO

Founding Team

Hedera Dx Investors

Notable investors and investment history

Hedera Dx investors
InvestorRounds
ReykVCSeries A
Top Harvest CapitalSeed, Series A
TesiSeries A
Air Street CapitalSeed
Top Harvest CapitalSeed
Eyrir Venture ManagementSeries A
Amino CollectiveSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 27, 2025

    $17M round completed.

Hedera Dx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hedera Dx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hedera Dx's valuation, stock price, and market status.

Firmographic Details

HeadquartersEpalinges
Employee Range37
Year Founded2021
Last FundingMay 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.